Since Brett Veach took over as general manager in 2018, the Chiefs have traded up four times for their initial section of any ...

We take a closer look at a clever spring-loaded butcher tool, explaining how it works, what it’s used for, and why it’s such ...

One month will define the Colorado Buffaloes' future. January brings a bevy of roster-building opportunities for coach Deion ...

NFL player and New England Patriots wide receiver Stefon Diggs, who recently welcomed a child with singer Cardi B, is facing ...

It's Christmas Day and the Denver Broncos are playing football! The Broncos (12-3) will take on the Kansas City Chiefs (6-9) at Arrowhead Stadium and though the Chiefs have had an incredibly ...

Chiefs salary cap 2026, explained: Why Kansas City is facing major roster management concerns originally appeared on The ...

This chapter opens like a love-hate purchase story: shiny carb covers, fresh wheels, thick leaf springs, and a narrator determined to prove whether squarebodies are truly “rock” durable or just ...

This article has been revised and clarified. Pasadena-based biopharma company Arrowhead Pharmaceuticals Inc. had a double-dose of good news last month. On Nov. 18, Arrowhead announced that it had ...

Arrowhead Game Studios has already begun work on its next game, but how does a developer follow a galactic success as beloved as Helldivers 2? Former CEO and current CCO Johan Pilestedt says whatever ...

FDA approved Plozasiran (now REDEMPLO™) on November 18, 2025, for reducing triglycerides in adults with FCS, the first siRNA therapy for this rare disease. ARWR boasts a diversified RNAi pipeline ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The Kansas City Chiefs have been one of the NFL’s most dominant teams of the last decade, winning three Super Bowl championships and playing in seven straight AFC Championship games. And while the ...